FDA Inspection
Fagron Compounding ServicesFagron Compounding Services – FDA Inspection, Aug 8, 2025
Record Details
This FDA Inspection record concerns Fagron Compounding Services, with an inspection on August 8, 2025, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · 158e972e-9f28-475f-a815-78fa4b7aff42
Inspection Facts
- Inspection number
- 1273014
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.25(c)Inadequate number of personnel
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fagron Compounding Services
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fagron Compounding Services
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.